BRCA1 and breast carcinoma: Specifically, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment published in 2010 provided recommendations for testing for high-penetrance breast cancer susceptibility genes (including BRCA1 and BRCA2) based on factors including a young age at diagnosis and family history [38].